Dr. David E. Pascoe, MD

Dr. Pascoe practices at Family Dermatology of North Florida in Tallahassee, Florida.

Dr. Pascoe's NPI, 1003038555, was assigned on May 3, 2007. Dr. Pascoe graduated from Duke University School Of Medicine in 2004. Dr. Pascoe holds Florida license ME101486.

Dr. Pascoe's primary practice is Family Dermatology of North Florida, at 1903 Welby Way, Tallahassee, FL 32308 in Leon County. The practice phone is (850) 402-9444.

Dr. Pascoe's primary practice is Family Dermatology of North Florida in Tallahassee, Florida. The medical group on file is Family Dermatology of North Florida. Dmand AI also links Dr. Pascoe to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pascoe practices. Vendor and product names are available with a free account.

Dermatology is Dr. Pascoe's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Pascoe is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Pascoe's licenses on file in 2 states: Florida and North Carolina.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Pascoe treats.

CMS data shows 6,525 Medicare services from Dr. Pascoe across 19 procedure codes in 2024, for 717 Medicare patients. Medicare paid $175,591 for them. Every service was in an office.

CMS counts 717 Medicare patients who saw Dr. Pascoe in 2026. The largest group is 65 to 74, with 323 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pascoe's median patient age at 67, with 54% women.

In 2026, Dr. Pascoe wrote 1,650 Medicare Part D claims for 631 patients. 96% of them were for generic drugs. CMS names the drug for 1,509 of them, across 19 drugs with 11 or more claims each, at $203,290 in total drug cost. In 2023, CMS named 1,490 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Pascoe for performance year 2026, reported as part of a group. Dr. Pascoe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,392 procedures of removal of skin lesions by Dr. Pascoe, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Pascoe.

Dmand AI links Dr. Pascoe to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 384 general payments to Dr. Pascoe from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $1,231.

Dmand AI lists 1 award for Dr. Pascoe.

Dr. Pascoe graduated from Duke University School Of Medicine in 2004. Dr. Pascoe is a member of AAD.

Dr. Pascoe is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.